The ACON Biotech Flowflex antigen rapid test with pre-filled buffer solution is approved for the qualitative detection of SARS-CoV-2 nucleocapsid antigens in nasal swab samples, and according to the bridging test of the Paul-Ehrlich-Institut, detects the Omicron variant.

EU-HSC (Joint EU Coronavirus Test Regulation of June 29, 2022)

BfArM listed AT1217/21

Evaluated according to the guidelines of the Paul-Ehrlich-Institut

CE certified according to: TÜV SÜD (CE0123)

EU-RAT list (yes)

PEI list-05.05.2022

Pre-filled buffer solution

Sensitivity: 97.1%

Specificity: 99.5%

Accuracy: 98.8%

Acon Flowflex sample collection: Anterior nasal swab samples

Test results in just 15 minutes

Excellent performance compared to molecular methods

Storage temperature: 2-30 ℃